Concepedia

Ranabir SinhaRoy

RS

18

Publications

1.6K

Citations

17

H-Index

2006

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

IRBM Science Park

Centro di Ricerca per la Patologia Vegetale

United States Military Academy

Ranabir SinhaRoy is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2006–2019

18

Publications

18

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Alessandro Pocai, Paul E. Carrington, Jennifer R. Adams et al. · Diabetes · 2009 · 405 citations · Full text

Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1

Elizabeth Migoya, Raynald Bergeron, Jutta Miller et al. · Clinical Pharmacology & Therapeutics · 2010 · 175 citations

Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes

Tesfaye Biftu, Ranabir SinhaRoy, Ping Chen et al. · Journal of Medicinal Chemistry · 2014 · 167 citations · Full text

, , +14

Optimization of co‐agonism at GLP‐1 and glucagon receptors to safely maximize weight reduction in DIO‐rodents

Jonathan W. Day, Vasily M. Gelfanov, David L. Smiley et al. · Biopolymers · 2012 · 134 citations

The Glucagon Receptor Is Involved in Mediating the Body Weight‐Lowering Effects of Oxyntomodulin

Jennifer Kosinski, James Hubert, Paul E. Carrington et al. · Obesity · 2012 · 106 citations · Full text

, , +21

Rows per page

1–5 of 18